AI in drug development is a vague term that might mean many things, and today, Owkin is announcing it has enrolled the first patient in a phase 1 study of OKN4395, its “AI-optimized” candidate for ...

Michael Kratsios, who served in the White House and Defense Department in the first Trump administration, is a policy ...

A health and nutrition expert shares insights from the NIH-FDA Nutrition Regulatory Science Workshop, including the ...

High-quality milk remains in high demand, but managing the health of dairy cows is becoming increasingly challenging. To tackle this, researchers from Tokyo University of Science have developed an ...